Key Insights

Highlights

Success Rate

78% trial completion

Published Results

12 trials with published results (8%)

Research Maturity

52 completed trials (36% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.3%

15 terminated out of 146 trials

Success Rate

77.6%

-8.9% vs benchmark

Late-Stage Pipeline

15%

22 trials in Phase 3/4

Results Transparency

23%

12 of 52 completed with results

Key Signals

12 with results78% success15 terminated

Data Visualizations

Phase Distribution

94Total
Not Applicable (52)
Early P 1 (2)
P 1 (7)
P 2 (11)
P 3 (7)
P 4 (15)

Trial Status

Completed52
Recruiting30
Unknown25
Terminated15
Active Not Recruiting14
Withdrawn5

Trial Success Rate

77.6%

Benchmark: 86.5%

Based on 52 completed trials

Clinical Trials (146)

Showing 20 of 20 trials
NCT06688825Not ApplicableRecruitingPrimary

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

NCT03206801Phase 2CompletedPrimary

Urine CXCL10 Monitoring Trial in Kidney Transplant

NCT04123951Not ApplicableActive Not RecruitingPrimary

Home-based Exercise in Renal Transplant Recipients

NCT05836636Completed

Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study

NCT03301558Phase 2WithdrawnPrimary

The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients

NCT04984902Not ApplicableWithdrawn

Reduction of BK Viremia in Kidney Transplant Patients

NCT06030609Phase 3Completed

The Comparison Between Ringer Lactate Solution and Normal Saline With Dextrose Water in Post-Operative Period of Kidney Transplantation

NCT03841097Phase 4Active Not RecruitingPrimary

Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants

NCT07531966Recruiting

Vascular Complications After Kidney Transplantation

NCT06059664Phase 2RecruitingPrimary

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

NCT05449496Not ApplicableActive Not RecruitingPrimary

Dietary Intervention to Improve Kidney Transplant Outcomes

NCT06001320Phase 3Active Not RecruitingPrimary

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients

NCT06798909Phase 3Recruiting

Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients

NCT04369456Not ApplicableCompletedPrimary

Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients

NCT06538961Recruiting

Immune Registry for BK in Kidney Transplant Recipients

NCT04906213Phase 2TerminatedPrimary

CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients

NCT06234410Recruiting

Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation

NCT07083830Phase 1Not Yet Recruiting

ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants

NCT04783441Not ApplicableRecruitingPrimary

Use of CGM in Kidney Transplant Recipients

NCT04364126Not ApplicableTerminated

Home Blood Pressure Monitoring in Kidney Transplant Recipients

Scroll to load more

Research Network

Activity Timeline